AmgenvsInsulet

AMGN and PODD stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$457.72

Value $247B

-0.99%
AMGN's page

PODD

Insulet Corporation

$146.40

Value $10.3B

+0.76%
PODD's page

Amgen (AMGN) has a market value of $247B and Insulet (PODD) $10.3B. Over the last year, with dividends, AMGN moved +39.5% and PODD -56.0%. The P/E is 26.3 for AMGN and 24.0 for PODD. Dividend yield: AMGN 2.17%, PODD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$247B

    PODD$10.3B

    AMGN is 24 times PODD

  • Revenue, 12 months

    AMGN$38.9B

    PODD$3.2B

    AMGN is 12 times PODD

  • Net income, 12 months

    AMGN$9.4B

    PODD$429M

    AMGN is 22 times PODD

  • Operating margin

    AMGN32.4%

    PODD18.4%

    14.0 points apart

  • ROIC

    AMGN16.2%

    PODD19.1%

    2.9 points apart

  • P/E

    AMGN26.3

    PODD24.0

    AMGN is 1.1 times PODD

  • Dividend yield

    AMGN2.2%

    PODD0.0%

    2.2 points apart

  • 5-year return

    AMGN+157.9%

    PODD-53.8%

    211.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+157.9%

PODD-53.8%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsPODDWith dividends
1 year since November 14, 2025+39.5%Price +35.8%-56.0%Price -56.0%
3 years since November 17, 2023+87.0%+23.2% a yearPrice +72.3%-15.9%-5.6% a yearPrice -15.9%
5 years since November 16, 2021+157.9%+20.9% a yearPrice +122.6%-53.8%-14.3% a yearPrice -53.8%
10 years since November 17, 2016+315.0%+15.3% a yearPrice +210.2%+293.0%+14.7% a yearPrice +293.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenPODDInsulet

Valuation

AMGNPODD
Valuation
Price$457.72$146.40
Market value$247B$10.3B
Enterprise value (EV)$288B$10.7B
P/E26.324.0
P/E, 5-year median23.073.8
P/B17.26.5
EV/EBIT22.818.2
Free cash flow yield3.9%2.5%

Results and growth

AMGNPODD
Results and growth
Revenue, 12 months$38.9B$3.2B
Net income, 12 months$9.4B$429M
Free cash flow, 12 months$9.6B$260M
Earnings per share, 12 months$17.25$6.13
Revenue growth, year on year10.0%30.7%
Revenue growth a year, past+7.6%over 5 years+24.5%over 5 years
EPS growth a year, past+2.9%over 5 years+103.4%over 5 years

Margins and returns on capital

AMGNPODD
Margins and returns on capital
Gross margin70.9%71.9%
Operating margin32.4%18.4%
Net margin24.1%13.5%
ROIC16.2%19.1%
ROE87.8%29.8%

Balance sheet

AMGNPODD
Balance sheet
Cash$13.2B$584M
Total debt$54.0B$962M
Net debt / EBITDA2.30.6
Interest cover4.8×9.9×

Dividends and buybacks

AMGNPODD
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–0.6%
Shareholder yield2.2%0.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or PODD

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Insulet?

By market value, Amgen ($247B) is about 23.9 times Insulet ($10.3B), at today's prices.

How did AMGN and PODD stock do over the last 10 years?

Since November 17, 2016, AMGN's price moved +210.2% and PODD's +293.0%. With dividends: AMGN +315.0% (+15.3% a year), PODD +293.0% (+14.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or PODD?

The dividend yield at today's price is 2.17% for Amgen and none for Insulet. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and PODD?

At today's price, the P/E is 26.3 for AMGN and 24.0 for PODD. The median of the last five years was 23.0 and 73.8, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Insulet?

Over the last twelve months, the net margin was 24.1% for Amgen and 13.5% for Insulet, and the operating margin 32.4% and 18.4%. Revenue was $38.9B and $3.2B.

Which is the better investment, Amgen or Insulet?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.